Motley Fool Premium
  1. Stocks
    2. /
  2. Novacyt (LSE: NCYT)
    3. /

LSE:NCYT (Novacyt)

About NCYT

Novacyt SAS engages in the development and sale of cancer and infectious disease diagnostic products. It operates through the Corporate and Diagnostics; and Molecular Products segments. The Corporate and Diagnostics segment includes diagnostic activities in laboratories, and the manufacturing and distribution of reagents and kits for bacterial and blood tests. The Molecular Products segment comprises of design, manufacture, and distribution of test kits for certain diseases in humans, animals and food products. The company was founded by Eric Peltier, Gerald Ulrich, and Jean-Pierre Crinelli on July 3, 2006 and is headquartered in Velizy-Villacoublay, France.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Novacyt (LSE: NCYT) Latest News

Investing Articles

The Novacyt share price just slumped! Here’s why?

| Dr. James Fox

The Novacyt share price dropped on Tuesday morning after the firm updated shareholders on a dispute with the UK government.

Read more »

Investing Articles

Is the Novacyt (LON:NCYT) share price now a screaming buy?

| Alan Oscroft

The Novacyt share price boomed on the back of demand for its Covid test kits. But that bubble has burst,…

Read more »

Investing Articles

The Novacyt share price is down 77% in a year – is it now a glaring buy?

| Andrew Woods

After the company's successful roll out of Covid testing kits, is the Novacyt share price now attractive for a long-term…

Read more »

Investing Articles

The Novacyt (LON:NCYT) share price continues to tumble on delays

| Zaven Boyrazian, MSc

The Novacyt (LON:NCYT) share price continues to decline after pandemic disruptions cause a six-month delay in new product launches.

Read more »

Investing Articles

Is this why the Novacyt share price keeps falling?

| Rupert Hargreaves

Rupert Hargreaves explains why the Novacyt share price is sliding and could remain under pressure as the company's profits fall.

Read more »

Investing Articles

What’s going on with the Novacyt (NCYT) share price?

| Zaven Boyrazian, MSc

After months of decline, the Novacyt (NCYT) share price started rising last month. Is this a sign to buy? Zaven…

Read more »

Investing Articles

3 dirt-cheap AIM stocks. Should I buy?

| Paul Summers

Paul Summers picks out three lowly-valued AIM stocks that could turn out to be huge bargains in time. But are…

Read more »

Syringe and vial on blue background
Investing Articles

The Novacyt (NCYT) share price: is it set to soar again?

| Alan Oscroft

The Novacyt share price (LON: NCYT) collapsed earlier in 2021. But the latest news has sent it heading upwards again.…

Read more »

Investing Articles

Is the Novacyt (NCYT) share price about to bounce back?

| Roland Head

The Novacyt share price is rising today. Is the worst over for shareholders, or do risks remain? Roland Head looks…

Read more »

Investing Articles

Should I buy Novacyt shares at under 400p?

| Roland Head

The Novacyt share price is rising today, but 45% of the company's 2020 sales are under dispute. Can the company…

Read more »

Woman sneaker shoe and Arrow on street with copy space background
Investing Articles

Can the Novacyt (NCYT) share price make a comeback?

| Zaven Boyrazian, MSc

The Novacyt (NCYT) share price has had a rough year, falling by nearly 60% since January. But is it about…

Read more »

Investing Articles

What’s happening to the Novacyt share price?

| Zaven Boyrazian, MSc

The Novacyt share price surged 6,000% in 2020. But this year, the stock has plummeted. Zaven Boyrazian investigates what’s happened.

Read more »